首页> 外文会议>International Commercialization of Micro and Nano Systems Conference; 20050821-25; Baden-Baden(DE) >A Micro Device for Blood/Plasma Separation as an Example of a Successful Development and Fabrication Strategy
【24h】

A Micro Device for Blood/Plasma Separation as an Example of a Successful Development and Fabrication Strategy

机译:用于血液/血浆分离的微型设备,作为成功开发和制造策略的示例

获取原文
获取原文并翻译 | 示例

摘要

The strategy for a successful product development in the micro system market is a demand driven development instead of one driven by the capabilities of a technology. The real challenge is providing sophisticated technical solutions and the capabilities for fabrication and integration into preexisting systems as well. A lot of prototypes have been developed in recent years that fail the last step of transfer to a product. This work demonstrates a successful development and fabrication of a microfluidic device for blood/plasma separation as a part of a technology platform for blood analysis. Conditions for a successful and efficient realization of such a project are a simultaneous engineering strategy, well-trained engineers with expert knowledge, and precise objectives for the final product. The novel blood/plasma separation technique is based on a simple microchannel bend structure. The mold fabrication by an enhanced UV-LIGA process and polymer replication by injection molding enable an easy and quick fabrication of a series of chips in the preferred polymer material and with preferred surface characteristics. This facilitates the evaluation of the chip application at an early stage in the development process. Due to fast and cost effective processing, different designs can be tested before a final decision on a fluidic design is made . This means more efficient design validations, reduced product development costs, and saved product development times. The separation device performs the required specifications of the final blood diagnostic system with blood cell separation efficiencies of more than 95 % and a plasma yield of 10%.
机译:在微系统市场中成功开发产品的策略是需求驱动的开发,而不是技术能力驱动的策略。真正的挑战是提供复杂的技术解决方案以及制造和集成到现有系统的功能。近年来,已经开发了许多原型,但没有将其转移到产品的最后一步。这项工作证明了用于血液/血浆分离的微流体装置的成功开发和制造,该装置是血液分析技术平台的一部分。成功而有效地实现这样一个项目的条件是同时进行的工程策略,训练有素的具有专业知识的工程师以及最终产品的精确目标。新颖的血液/血浆分离技术基于简单的微通道弯曲结构。通过增强的UV-LIGA工艺进行模具制造,以及通过注塑成型进行聚合物复制,可以轻松快速地在优选的聚合物材料中并具有优选的表面特性来制造一系列切屑。这有助于在开发过程的早期阶段评估芯片应用。由于快速且具有成本效益的处理,在做出关于流体设计的最终决定之前,可以测试不同的设计。这意味着更有效的设计验证,降低的产品开发成本和节省的产品开发时间。分离装置以超过95%的血细胞分离效率和10%的血浆产率执行最终血液诊断系统所需的规格。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号